COVID-19 outpatients - early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: a retrospective case series study
OPEN International journal of antimicrobial agents | 31 Oct 2020
R Derwand, M Scholz and V Zelenko
To describe outcomes of patients with coronavirus disease 2019 (COVID-19) in the outpatient setting after early treatment with zinc, low dose hydroxychloroquine, and azithromycin (triple therapy) dependent on risk stratification.
* Data courtesy of Altmetric.com